Casella, D.; Palumbo, P.; Sandroni, S.; Caponi, C.; Littori, F.; Capuano, F.; Grimaldi, L.; Marcasciano, M.; Cuomo, R.
Positive ROS (Reactive Oxygen Species) Modulator Engineered Device Support Skin Treatment in Locally Advanced Breast Cancer (LABC) Enhancing Patient Quality of Life. J. Clin. Med. 2022, 11, 126.
https://doi.org/10.3390/jcm11010126
AMA Style
Casella D, Palumbo P, Sandroni S, Caponi C, Littori F, Capuano F, Grimaldi L, Marcasciano M, Cuomo R.
Positive ROS (Reactive Oxygen Species) Modulator Engineered Device Support Skin Treatment in Locally Advanced Breast Cancer (LABC) Enhancing Patient Quality of Life. Journal of Clinical Medicine. 2022; 11(1):126.
https://doi.org/10.3390/jcm11010126
Chicago/Turabian Style
Casella, Donato, Paolo Palumbo, Sara Sandroni, Claudio Caponi, Francesca Littori, Francesca Capuano, Luca Grimaldi, Marco Marcasciano, and Roberto Cuomo.
2022. "Positive ROS (Reactive Oxygen Species) Modulator Engineered Device Support Skin Treatment in Locally Advanced Breast Cancer (LABC) Enhancing Patient Quality of Life" Journal of Clinical Medicine 11, no. 1: 126.
https://doi.org/10.3390/jcm11010126
APA Style
Casella, D., Palumbo, P., Sandroni, S., Caponi, C., Littori, F., Capuano, F., Grimaldi, L., Marcasciano, M., & Cuomo, R.
(2022). Positive ROS (Reactive Oxygen Species) Modulator Engineered Device Support Skin Treatment in Locally Advanced Breast Cancer (LABC) Enhancing Patient Quality of Life. Journal of Clinical Medicine, 11(1), 126.
https://doi.org/10.3390/jcm11010126
